Pittsburgh biotech firms see potential benefits from upcoming tariffs and reshoring efforts, despite uncertainties in NIH ...

STAT's Adam Feuerstein puts all his “Biotech Doom Loop” panic-mongering aside, as he embraces luminescent moonbeams and downy ...

The round also saw participation from Huddle, Campus Fund, Blume Founders Fund, and angel investors including Nitin Sharma (Nexus Venture Partners) and Sameer Brij Verma (Northpoint Capital).

Huddle, Campus Fund, Blume Founders Fund, and angel investors Nitin Sharma and Sameer Brij Verma participated in the funding ...

Repertoire Immune Medicines will get $35 million upfront, and possibly $730 million more, in a deal to help Roche’s Genentech ...